Nanobiotix
Business Services · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
60 Rue De Wattignies, Paris, Ile-de-Fran...Phone Number
+33 140260470Website
www.nanobiotix.comRevenue
$7.2 MillionStock Symbol
NBTXIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
1
1
1
1
1
About Nanobiotix
Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity. The company's philosophy is rooted in the concept of pushing past the boundaries of what is known to expand possibilities for human life. Incorporated in 2003, Nanobiotix is headquartered in Paris, France. The company also has subsidiaries in Cambridge, Massachusetts (United States), France, Spain, Germany and Switzerland. Nanobiotix has been listed on the regulated market of Euronext in Paris since 2012 and on the Nasdaq Global Select Market in New York City since December 2020.Explore more
Nanobiotix Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nanobiotix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Nanobiotix
Click to see if Nanobiotix had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Nanobiotix launches new products
Funding: Get notified immidiatlly once Nanobiotix has new funding data
Nanobiotix, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Nanobiotix has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Nanobiotix recently announced quarterly report
Check out if Nanobiotix is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Nanobiotix as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Nanobiotix is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Nanobiotix is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Nanobiotix.
Nanobiotix financials insights
Gather financial insights about Nanobiotix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$11.3M
Stock Offering
$99M
2025
Other Financing Round
$71M
2026
Stock/Share Issuance
$100M
Nanobiotix Tech Stack
A closer look at the technologies used by Nanobiotix
See more technologies
Most Recent Scoops
Funding
Funding
Person-Based
Person-Based
Person-Based
Person-Based
Nanobiotix News & Media
Voting Rights and Shares Capital of the Company
PARIS, July 30, 2026 (GLOBE NEWSWIRE) -- In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)Nanobiotix (NBTX) Provides Update on Operational Progress
Nanobiotix S.A. (NASDAQ:NBTX) is one of the best small cap stocks to buy for the long term. Nanobiotix S.A. (NASDAQ:NBTX) announced on June 2 an update on operational progress and reported financial results for the first quarter of 2026. The company reported €42.1 million in cash and cash equivalents as of March 31, 2026, adding that it […]Voting Rights and Shares Capital of the Company
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)Nanobiotix Provides First Quarter 2026 Operational and Financial Update
PARIS and CAMBRIDGE, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, today provided an update on operational progress and reported financial results for the first quarter of 2026.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nanobiotix
Sign Up For FreeTo access detailed company insights
Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity. The company's philosophy is rooted in the concept of pushing past the boundaries of what is known to ex... Read More
